Yong Hyun Lee

Dr. Yong Hyun Lee

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
XZXinrui Zhang
Xinrui Zhang
TTThuy Tien Thi Trinh
Thuy Tien Thi Trinh
LLLinh Thi Thuy Le
Linh Thi Thuy Le
NGNguyen Ngan Giang
Nguyen Ngan Giang
YJYongxun Jin
Yongxun Jin
CHChan Yeong Heo
Chan Yeong Heo
The PlazMagik device is a dual-gas cold atmospheric plasma (CAP) system that was developed and used for skin rejuvenation and inflammation treatment. However, preclinical evaluation and optimization of plasma parameters are crucial for guaranteeing safety. Therefore, this study was performed to evaluate the safety of the PlazMagik device under multiple parameters with different gas resources (helium (He) and argon (Ar) gases) on pig dorsal skin. After application of PlazMagik to the pig’s dorsal skin, temperature and visual assessments were observed immediately and for up to 30 days. All clinical parameters, including body weight and blood serum biochemistry, along with histopathological analysis (H&E, MT, VB, NBTC staining), were monitored pre-application and at 1, 7, 15, and 30 days post-application of the plasma device. Our results confirmed the safety of the machine at low-output energy settings, which showed gentle skin exfoliation but no tissue damage, while high-output settings led to the skin erosion effect, then developing erythema and coagulation. Ar gas resulted in more significant heat production and pathological changes than He under identical conditions. These findings emphasize the importance of the preclinical evaluation of the energy settings and gas selection on optimizing CAP system performance for safe clinical applications and appropriate application purposes.

Verified
Journal Article
Open access
PDF file
XZXinrui Zhang
Xinrui Zhang
LLLinh Thi Thuy Le
Linh Thi Thuy Le
YJYongxun Jin
Yongxun Jin
CJCaijun Jin
Caijun Jin
NGNguyen Ngan Giang
Nguyen Ngan Giang
CHChan Yeong Heo
Chan Yeong Heo
Wound healing remains a significant clinical challenge worldwide, and effective management strategies are essential for improving outcomes. This study evaluated SCderm Matrix, a novel acellular dermal matrix (ADM) patch developed using supercritical carbon dioxide (sCO2) processing of human skin tissue. This innovative processing method preserves structural integrity while enhancing biocompatibility, resulting in a patch characterized by porous architecture, uniform thickness, excellent tensile strength, and optical transparency. In vivo wound healing experiments using full-thickness skin wounds in Sprague–Dawley rats demonstrated the patch’s superior performance. Treatment with the sCO2 ADM patch accelerated wound closure, reduced inflammation, and enhanced granulation tissue formation compared to both untreated controls and two commercially available ADM products. Histological analysis revealed improved re-epithelialization and collagen deposition, while molecular and immunohistochemical assessments showed decreased reactive oxygen species (ROS) and pro-inflammatory cytokines. Simultaneously, the treatment upregulated key proliferation and remodeling markers including alpha smooth muscle actin (α-SMA), vimentin, and transforming growth factor beta 1 (TGF-β1). These findings demonstrate that the SCderm Matrix promotes wound healing through multiple mechanisms: modulating inflammatory responses, enhancing antioxidant defenses, and supporting tissue regeneration. The results suggest this biomaterial has significant potential as an effective and versatile solution for clinical wound care applications.

13 December 2025 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
CJCaijun Jin
Caijun Jin
YCYoun Jeong Cha
Youn Jeong Cha
HKHee Eun Kim
Hee Eun Kim
YJYongxun Jin
Yongxun Jin
XZXinrui Zhang
Xinrui Zhang
CHChan Yeong Heo
Chan Yeong Heo
Objective: This study was to evaluate the effects of a composite extract of Prunus mume flower, Lonicera japonica flower (honeysuckle), Chrysanthemum indicum flower, and Phyllostachys bambusoides , which we named PLCP, on skin hydration, inflammation, itching, and oxidative stress in pediatric (NHEK) and adult (HaCaT) keratinocytes. Methods: LPS was used to simulate the external stimulation for pediatric (NHEK) and adult (HaCaT) keratinocytes. These keratinocytes were treated with different concentrations of PLCP, and the expression of inflammation, itching, and oxidative stress‐related proteins or mRNA was observed through rt‐PCR, ELISA, ROS, and SOD. Meanwhile, rt‐PCR was also used to determine the expression of Hyaluronic acid synthase (HAS) in keratinocytes under PLCP intervention for its moisturizing effects. Results: PLCP treatment (0.125%–0.500%) significantly suppressed LPS‐stimulated thymic stromal lymphopoietin (TSLP) secretion by up to 40.3% in pediatric cells and 29.9% in adult cells ( p < 0.05), and reduced endothelin‐1 (ET‐1) mRNA levels by up to 69.5% and 46.0%, respectively ( p < 0.05). Concurrently, PLCP dose‐dependently upregulated hyaluronic acid synthase isoforms (HAS‐1, HAS‐2, HAS‐3) mRNA expression by 174.8%–254.2% in pediatric keratinocytes and 143.5%–198.9% in adult cells ( p < 0.05), indicating enhanced hydration potential. Antioxidant assays demonstrated that PLCP at 0.250% decreased reactive oxygen species (ROS) by 55.3% in pediatric and 41.6% in adult cells, while boosting superoxide dismutase (SOD) activity ( p < 0.05). Conclusions: Across all endpoints, pediatric keratinocytes exhibited more pronounced responses, suggesting age‐dependent differences in sensitivity. These in vitro findings support PLCP's multifunctional role at anti‐inflammatory, anti‐pruritic, moisturizing, and antioxidant and highlight its promise as a safe, plant‐based alternative for managing pediatric skin disorders.

Verified
Journal Article
Open access
PDF file
YJYongxun Jin
Yongxun Jin
YLYong Hyun Lee
Yong Hyun Lee
DKDo Hwan Kim
Do Hwan Kim
CJCaijun Jin
Caijun Jin
XZXinrui Zhang
Xinrui Zhang
CHChan Yeong Heo
Chan Yeong Heo
Wound healing remains a significant clinical challenge worldwide, and effective management strategies are essential for improving outcomes. This study investigates the therapeutic potential of the AcuCool™ system, a novel multifunctional device that combines high-velocity CO2 cryotherapy with intradermal delivery of epidermal growth factor (EGF), in promoting wound healing. Using a full-thickness skin wound model in Sprague Dawley rats, we compared the effects of Device+EGF treatment to those of conventional microneedling-based EGF delivery and untreated controls. Macroscopic assessments revealed significantly accelerated wound closure in the Device+EGF group. Histological analysis showed enhanced re-epithelialization, reduced inflammatory cell infiltration, and increased collagen deposition. Molecular evaluations further demonstrated downregulation of pro-inflammatory markers (TNF-α, IL-1β, MCP-1) and upregulation of remodeling-related genes including TGF-β1, Collagen I, and Vimentin. In addition, nitrite assays confirmed reduced local nitric oxide levels, indicating suppression of oxidative stress. The AcuCool™ platform offers precise, non-invasive drug delivery with dual physical and biochemical therapeutic mechanisms, enabling superior control of inflammation and tissue regeneration. These findings suggest that AcuCool™ represents a promising therapeutic strategy for accelerating wound healing in acute models. While further studies are warranted in chronic wound settings, this approach may hold translational potential for future clinical applications.